We also compared several clinical parameters; i.e., age at CLL diagnosis, DLBCL subtype, and the number of CLL therapy cycles received, but did not find significant differences between CARD9-positive and -negative cases in this small cohort (Supplementary Table S2). The gene discussed is CARD9; the disease is B-cell chronic lymphocytic leukemia.